202653-32-5 Usage
Description
((S)-3-Oxo-4-phenethyl-piperazin-2-yl)-acetic acid tert-butyl ester is a chiral molecule and a derivative of piperazine, characterized by a six-membered ring with two nitrogen atoms. It is a tert-butyl ester of an acetic acid derivative and features a phenethyl group attached to the piperazine ring. The (S)-enantiomer has a specific spatial arrangement of atoms, which may contribute to its potential pharmaceutical or biological applications.
Uses
Used in Pharmaceutical Industry:
((S)-3-Oxo-4-phenethyl-piperazin-2-yl)-acetic acid tert-butyl ester is used as a potential pharmaceutical candidate due to its structural features and the presence of a piperazine moiety, which is common in various drugs. Its chiral nature and specific spatial arrangement may offer unique properties for medicinal chemistry applications.
Used in Biological Research:
((S)-3-Oxo-4-phenethyl-piperazin-2-yl)-acetic acid tert-butyl ester is used as a subject of study in biological research to explore its exact properties and potential uses. Further investigation may reveal its interactions with biological systems and its efficacy in treating specific conditions or diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 202653-32-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,2,6,5 and 3 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 202653-32:
(8*2)+(7*0)+(6*2)+(5*6)+(4*5)+(3*3)+(2*3)+(1*2)=95
95 % 10 = 5
So 202653-32-5 is a valid CAS Registry Number.
202653-32-5Relevant articles and documents
Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2- oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide
Sugihara, Hirosada,Fukushi, Hideto,Miyawaki, Toshio,Imai, Yumi,Terashita, Zen-Ichi,Kawamura, Masaki,Fujisawa, Yukio,Kita, Shunbun
, p. 489 - 502 (2007/10/03)
Based on the lead tetrapeptide RGDF, two possible non-peptide glycoprotein (GP) IIb-IIIa antagonists possessing an (S)-2-oxopiperazine-3- acetic acid moiety as a scaffold incorporating the indispensable Asp fragment were prepared, and (S)-4-[[trans-[4-(gu
